Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit. / A, Raza; G, Muhammad; S U, Rahman; I, Rashid; K, Hanif; A, Atta; S, Sharif.

In: Iranian Journal of Veterinary Research, Vol. 16, No. 1, 2015, p. 69-74.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

A, R, G, M, S U, R, I, R, K, H, A, A & S, S 2015, 'Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit', Iranian Journal of Veterinary Research, vol. 16, no. 1, pp. 69-74.

APA

A, R., G, M., S U, R., I, R., K, H., A, A., & S, S. (2015). Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit. Iranian Journal of Veterinary Research, 16(1), 69-74.

Vancouver

A R, G M, S U R, I R, K H, A A et al. Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit. Iranian Journal of Veterinary Research. 2015;16(1):69-74.

Author

A, Raza ; G, Muhammad ; S U, Rahman ; I, Rashid ; K, Hanif ; A, Atta ; S, Sharif. / Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit. In: Iranian Journal of Veterinary Research. 2015 ; Vol. 16, No. 1. pp. 69-74.

Bibtex

@article{c0d7f54cde524a9ca8d0c18a5ce3fdd0,
title = "Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit",
abstract = "Mastitis is a one of the major diseases of dairy animals. Staphylococcus aureus is the most common microorganism associated with this dairy scourge. Cure rates of mastitis associated with this pathogen are appallingly low. Biofilm is an important virulence factor and immunogenic structure of S. aureus that makes it resistant to phagocytosis and antibiotics. Reports on the efficacy of vaccine prepared from a biofilm producing S. aureus are infrequent. The present study was designed to evaluate the role of a bacterin-toxoid prepared from a strong biofilm producing S. aureus in effective immunization of rabbits. The strong biofilm producing S. aureus selected from 64 isolates of staphylococci was used to prepare bacterin-toxoid and aluminum hydroxide gel was added as an adjuvant. The vaccine was evaluated in rabbits by challenge protection assay and humoral immune response. The mortality rates in control and vaccinated groups were 80% and 10% at day 7 post challenge and 100% and 20% at day 15 post challenge, respectively. Serum antibody titer (GMT) was significantly higher (294.0) in vaccinated group as compared to control group of rabbits (2.63) at day 45. The results showed that the vaccine has significantly elicited humoral immune response in rabbit and developed protective efficacy against new infections.",
author = "Raza A and Muhammad G and {S U}, Rahman and Rashid I and Hanif K and Atta A and Sharif S",
year = "2015",
language = "English",
volume = "16",
pages = "69--74",
journal = "Iranian Journal of Veterinary Research",
issn = "1728-1997",
publisher = "Shiraz University",
number = "1",

}

RIS

TY - JOUR

T1 - Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit

AU - A, Raza

AU - G, Muhammad

AU - S U, Rahman

AU - I, Rashid

AU - K, Hanif

AU - A, Atta

AU - S, Sharif

PY - 2015

Y1 - 2015

N2 - Mastitis is a one of the major diseases of dairy animals. Staphylococcus aureus is the most common microorganism associated with this dairy scourge. Cure rates of mastitis associated with this pathogen are appallingly low. Biofilm is an important virulence factor and immunogenic structure of S. aureus that makes it resistant to phagocytosis and antibiotics. Reports on the efficacy of vaccine prepared from a biofilm producing S. aureus are infrequent. The present study was designed to evaluate the role of a bacterin-toxoid prepared from a strong biofilm producing S. aureus in effective immunization of rabbits. The strong biofilm producing S. aureus selected from 64 isolates of staphylococci was used to prepare bacterin-toxoid and aluminum hydroxide gel was added as an adjuvant. The vaccine was evaluated in rabbits by challenge protection assay and humoral immune response. The mortality rates in control and vaccinated groups were 80% and 10% at day 7 post challenge and 100% and 20% at day 15 post challenge, respectively. Serum antibody titer (GMT) was significantly higher (294.0) in vaccinated group as compared to control group of rabbits (2.63) at day 45. The results showed that the vaccine has significantly elicited humoral immune response in rabbit and developed protective efficacy against new infections.

AB - Mastitis is a one of the major diseases of dairy animals. Staphylococcus aureus is the most common microorganism associated with this dairy scourge. Cure rates of mastitis associated with this pathogen are appallingly low. Biofilm is an important virulence factor and immunogenic structure of S. aureus that makes it resistant to phagocytosis and antibiotics. Reports on the efficacy of vaccine prepared from a biofilm producing S. aureus are infrequent. The present study was designed to evaluate the role of a bacterin-toxoid prepared from a strong biofilm producing S. aureus in effective immunization of rabbits. The strong biofilm producing S. aureus selected from 64 isolates of staphylococci was used to prepare bacterin-toxoid and aluminum hydroxide gel was added as an adjuvant. The vaccine was evaluated in rabbits by challenge protection assay and humoral immune response. The mortality rates in control and vaccinated groups were 80% and 10% at day 7 post challenge and 100% and 20% at day 15 post challenge, respectively. Serum antibody titer (GMT) was significantly higher (294.0) in vaccinated group as compared to control group of rabbits (2.63) at day 45. The results showed that the vaccine has significantly elicited humoral immune response in rabbit and developed protective efficacy against new infections.

M3 - Journal article

C2 - 27175154

VL - 16

SP - 69

EP - 74

JO - Iranian Journal of Veterinary Research

JF - Iranian Journal of Veterinary Research

SN - 1728-1997

IS - 1

ER -

ID: 362933744